Li said that the challenges remain severe, with vaccines representing a strong shield to defend against the virus. He pointed out that China will continue to promote clinical trials in multiple centers, and facilitate market entrance as soon as possible, once the goals of research and development have been accomplished, so as to provide the world with a safe, effective and high-quality global public good.
Noting that China has been stepping up scientific research on COVID-19 vaccines, medicines, and testing reagents, Li said China attaches great importance to international cooperation in vaccine research and development.
China recently participated in the European Union (EU) COVID-19 online pledging conference, and is willing to continue to strengthen relevant cooperation with all parties, Li said.
GAVI has maintained good cooperation with China and has invested in supporting China's vaccination and international applications, said Li. He expressed the Chinese government's willingness to contribute to GAVI's funding cycle, encourage China's R&D institutions and vaccine manufacturers to strengthen collaboration with the GAVI, and support GAVI's important role in promoting the use of vaccines.
"We hope to work together to overcome the epidemic as soon as possible," Li said.
【国内英语资讯:Chinese premier delivers speech at global vaccine summit】相关文章:
★ 外套流行超大号
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15